Company news
Calcimedica, Inc. (NASDAQ:CALC) news
Every Calcimedica, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
CalciMedica Announces One-for-Five Reverse Stock Split
August 27, 2026
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
August 11, 2026
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Re...
July 29, 2026
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
June 24, 2026
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
June 24, 2026
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
May 12, 2026
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
March 3, 2026
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
January 28, 2026
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
November 12, 2025
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmona...
November 12, 2025
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
November 10, 2025
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of...
October 14, 2025
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
August 12, 2025
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
July 8, 2025
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxor...
June 25, 2025
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
June 12, 2025
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
May 14, 2025
CalciMedica Announces Presentations at Upcoming Medical Meetings
April 17, 2025
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference
April 1, 2025
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates
March 27, 2025
CalciMedica Secures Credit Facility for Up to $32.5 Million
March 5, 2025
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th In...
March 4, 2025
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
February 19, 2025
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
January 14, 2025
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical and Corporate Updates
November 14, 2024
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
November 13, 2024
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
November 7, 2024
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancrea...
October 30, 2024
CalciMedica Announces Proposed Public Offering of Common Stock
October 30, 2024
CalciMedica Announces Pricing of Public Offering of Common Stock
October 30, 2024
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancrea...
October 28, 2024
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific...
October 16, 2024
CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
August 12, 2024
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)
July 9, 2024
CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences
July 8, 2024
CalciMedica Set to Join Russell Microcap® Index
July 1, 2024
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
June 27, 2024
CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
June 26, 2024
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
May 13, 2024
CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
May 7, 2024
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
April 24, 2024
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
March 28, 2024
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
March 13, 2024
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT...
February 28, 2024
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury
February 13, 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million
January 22, 2024
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
November 9, 2023
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
November 2, 2023